More reports from IAS 2009
2 October 2009. Related: News.
- Raltegravir (Isentress) granted an expanded licence from the European Union Commission.
- Detention and removal of HIV-positive people in the UK.
In the July/August issue of HTB we reported results from the DART trial pesented at the 5th IAS conference.DART is an important study comparing clinical and laboratoy based monitoring sponsored by the MRC. We encourage readers to see full details from the many posters and presentations posted on the study website.